![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Shodhana Laboratories Private Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
They are recognized for Shodhana continues to entrench its position on R&D, scale-up and commercialization of APIs, with supplies to 50+ countries.
One of their significant offerings is Rivastigmine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2015-236 - Rev 00
This Chemical Type CEP, issued on August 19, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2629 associated with this CEP further emphasizes